Globus Medical stock is down today on an unexpectedly soft Q1 amid an earlier-than-planned integration with recently acquired ...

Discover key Q1 2025 insights from Globus Medical, including revenue trends, the Nevro acquisition, free cash flow growth, and future strategies.

Globus Medical, Inc.’s GMED share price has dipped by 21.03%, which has investors questioning if this is right time to buy.

Globus Medical will hold a teleconference to discuss its first quarter 2025 results with the investment community at 4:30 p.m. Eastern Time today. Participants may access the conference call live via ...

Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced ... unless the underlying item has a materially different tax treatment, in which case the estimated tax rate ...

About Globus Medical, Inc. Based in Audubon ... unless the underlying item has a materially different tax treatment, in which case the estimated tax rate applicable to the adjustment is used.

Those investments will be important in the long term, he said, because Edwards anticipates new indications for its technologies to expand the pool of patients eligible for treatment. Edwards expects ...

Globus Medical, Inc. (NYSE:GMED) just released its latest quarterly report and things are not looking great. It wasn't a great result overall - while revenue fell marginally short of analyst ...